634. Myeloproliferative Syndromes: Clinical and Epidemiological: Transplantation, COVID-19 and Biology Insights
313 ASH denotes this abstract as clinically relevant
Derek W Brown, Youjin Wang, Andrew St. Martin, et al.
See abstract for more info.
314 ASH denotes this abstract as clinically relevant
Nico Gagelmann, Anita Badbaran, Markus Ditschkowski, et al.
See abstract for more info.
315 ASH denotes this abstract as clinically relevant
Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, et al.
Ruxolitinib discontinuation is still a risk factor for a dismal outcome. See abstract for more info.
316 ASH denotes this abstract as clinically relevant
Joan How, Kathleen M.E. Gallagher, Yiwen Liu, et al.
See abstract for more info.
317 ASH denotes this abstract as clinically relevant
Lin-Pierre Zhao, Marine Cazaux, Nabih Maslah, et al.
See abstract for more info.
318 ASH denotes this abstract as clinically relevant
Michael W. Deininger, Daniel J. DeAngelo, Deepti H. Radia, et al.
See abstract for more info.